Disruption of IRE1 alpha through its kinase domain attenuates multiple myeloma.
Harnoss, J.M., Le Thomas, A., Shemorry, A., Marsters, S.A., Lawrence, D.A., Lu, M., Chen, Y.A., Qing, J., Totpal, K., Kan, D., Segal, E., Merchant, M., Reichelt, M., Ackerly Wallweber, H., Wang, W., Clark, K., Kaufman, S., Beresini, M.H., Laing, S.T., Sandoval, W., Lorenzo, M., Wu, J., Ly, J., De Bruyn, T., Heidersbach, A., Haley, B., Gogineni, A., Weimer, R.M., Lee, D., Braun, M.G., Rudolph, J., VanWyngarden, M.J., Sherbenou, D.W., Gomez-Bougie, P., Amiot, M., Acosta-Alvear, D., Walter, P., Ashkenazi, A.(2019) Proc Natl Acad Sci U S A 116: 16420-16429
- PubMed: 31371506 
- DOI: 10.1073/pnas.1906999116
- Primary Citation of Related Structures:  
6URC - PubMed Abstract: 
Multiple myeloma (MM) arises from malignant immunoglobulin (Ig)-secreting plasma cells and remains an incurable, often lethal disease despite therapeutic advances. The unfolded-protein response sensor IRE1α supports protein secretion by deploying a kinase-endoribonuclease module to activate the transcription factor XBP1s ...